Thomas meyer altamira therapeutics
WebNov 30, 2024 · “We continue to make good progress with the transformation of Altamira into an RNA delivery technology company,” stated Thomas Meyer, Altamira Therapeutics’ founder, Chairman and CEO. “We are optimistic of reaching an agreement to divest or partner our Bentrio nasal spray for key markets in North America and Europe by year end. WebApr 6, 2024 · Altamira’s OligoPhore™ / SemaPhore™ platform allows complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. We are currently developing two programs (AM …
Thomas meyer altamira therapeutics
Did you know?
Web2 days ago · "The demonstration of proof of concept in the TRAVERS trial marks a major milestone in the development of AM-125 as innovative treatment for acute vestibular syndrome," commented Thomas Meyer, Altamira Therapeutics' founder, Chairman and CEO. WebAuris Medical
WebApr 12, 2024 · Altamira Therapeutics gab die Veröffentlichung der detaillierten Ergebnisse seiner TRAVERS Phase 2-Studie mit AM-125 bei chirurgisch induziertem akutem vestibulärem Syndrom bekannt. ... Thomas Meyer: Chairman & Chief Executive Officer: Marcel Gremaud: Chief Financial Officer: Covadonga Pañeda: Chief Development Officer: … WebApr 13, 2024 · Altamira Therapeutics (NASDAQ:CYTO – Get Rating) and Viracta Therapeutics (NASDAQ:VIRX – Get Rating) ... AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda. About Viracta Therapeutics ...
WebAltamira Therapeutics (NASDAQ:CYTO) CEO Dr Thomas Meyer says the company has used last year's acquisition of Trasir Therapeutics to strategically focus its b... WebThomas Meyer. Age : 54. Public asset : 124,798 USD. Linked companies : Altamira Therapeutics Ltd. Summary. Founder of Auris Medical Holding AG, Altamira Therapeutics …
Web2 days ago · Altamira Therapeutics Announces ... marks a major milestone in the development of AM-125 as innovative treatment for acute vestibular syndrome," commented Thomas Meyer, Altamira Therapeutics ...
WebAug 3, 2024 · August 3, 2024. Thomas Meyer, Ph.D., Chairman and CEO. Altamira Therapeutics (NASDAQ:CYTO) is using its recent acquisition of closely-held Trasir … how to build your own walk in coolerWeb2 days ago · Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical ... The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton ... how to build your own wheelchairWebThomas Meyer founded Auris Medical in April 2003 and was the Company's sole shareholder until the end of 2007. Prior to founding Auris Medical, he was the Chief … how to build your own wine racks for homeWebAltamira Therapeutics Pharmaceutical Manufacturing Vi Partners Venture Capital and ... Thomas Meyer Chairman & CEO bei Altamira Therapeutics Ltd. Altamira Medica Altamira ... how to build your own website and make moneyWebApr 12, 2024 · -- Die Aktien von Altamira Therapeutics stiegen am Mittwoch um mehr als 53%, nachdem in der Fachzeitschrift Otology & Neurotology positive Ergebnisse der Phase 2-Studie mit AM-125 bei akutem... 13 April 2024 how to build your portfolio investmentWebOct 21, 2024 · Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that it has entered into an agreement regarding the sale of certain of its legacy assets comprised of its inner ear therapeutics research and development programs and a license to use its … how to build your own yoga practiceWebApr 10, 2024 · Altamira Therapeutics a publié les grandes lignes d'un article révisé par des pairs montrant l'efficacité de la bétahistine orale dans le traitement du vertige positionnel paroxystique bénin ... how to build your own wood scaffolding